EYITAYO ODENIYI: Open Payments
NPI 1215398532 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 41 payments from 4 companies in 2025. Trend: 2023 $359 · 2024 $409 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 21 | $376 |
| Neurocrine BioSciences, Inc. | 10 | $193 |
| Teva Pharmaceuticals USA, Inc. | 7 | $169 |
| ACADIA Pharmaceuticals Inc | 3 | $57 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, NUPLAZID.
Industry payments across TX — which companies pay providers there.
